Under the supervision of a medical team, New Scientist's Graham Lawton took a dose of MDMA and then lay in an fMRI machine. You know. For science.
Lawton was a participant in a double blind, controlled, clinical study — meaning that he didn't actually know whether he was going to be taking ecstasy or Vitamin C when he went in ... and neither did the scientists who gave him the pill. That's because the researchers want to know whether and what differences show up between the functioning of brain under the influence of MDMA and one that's sober. Not knowing which type of brain they're looking at helps them avoid their own biases, or tendencies to "spot" a difference that doesn't actually exist simply because of what they expect a high brain (or a sober one) to be doing. Only after they've made their observations do the scientists find out which brains were which.
The goal is to document was ecstasy does to the brain. Astoundingly, writes Lawton, nobody has ever done that before. And it matters, because some people think that drugs like ecstasy could be useful in helping people deal with psychological stress disorders. Not that the drugs would cure the disorder, per se, but that ecstasy could help people talk about their bad experiences more easily. Right now, there's not a lot of evidence supporting that idea, beyond some anecdotes. Studies like this help scientists figure out whether the anecdotes are pointing at a useful treatment tool, or just relating some personal experiences.
Read the story (and see a gallery of photos) at New Scientist
Via Jennifer Ouellette
Scientific American summarized five of Donald Trump’s “major moves many see as hostile toward science.” They are: • Trump’s pick for head of the U.S. Environmental Protection Agency has actively battled its mission “To lead the EPA, Trump appointed Scott Pruitt, the Oklahoma attorney general who has long opposed environmental regulations and has questioned the science […]
Why does The Caterpillar Lab only have 44 subscribers? Caterpillars set to smooth jazz, like these gorgeous stinging rose caterpillars checking each other out, make this New Hampshire nonprofit a hidden gem.
A paper from a group of Kings College London researchers documents an unexpected and welcome side effect from an experimental anti-Alzheimer’s drug called Tideglusib: test subjects experienced a regeneration of dentin, the bony part of teeth that sits between the pulp and the enamel.
With countless applications for modern life, artificial intelligence (AI) is one of the most in-demand fields of study in tech. Beyond modelling human decision making processes and learning abilities, AI can be used to analyze massive volumes of data and create complex interactive systems.This Machine Learning & AI for Business Bundle made mastering these concepts possible for […]
Computer hacking isn’t just something happening to the DNC. Major software companies need white-hat hackers to ensure the security of their products and users, and I came across a Computer Hacker Professional Certification Package that conveniently teaches those advanced IT techniques online.This course package will prepare you for various computer security certification exams with over 60 hours […]
One of the best ways to progress a career in project management is through earning recognized certifications. These certifications carry significant clout and don’t require expensive tuition or student loans. This Ultimate Project Management Certification Bundle is a great example of an affordable way to get ahead. It includes training for 9 certifications including PMP, […]